Article or book title, author's surname, DOI

Pharmacological investigation of antiulcerogenic action of the grape leaves red extract dry (Vitis vinifera L.)

Ю.А. Трифонов1, В.К. Колхир2, Т.А. Сокольская3, Е.В. Ферубко4, Т.Р. Курманов5

research article Pages: 64-69

  1. 1 д.б.н., гл. науч. сотрудник, лаборатория фармакологии, отдел экспериментальной и клинической фармакологии, Центр медицины, ГНУ ВИЛАР Россельхозакадемии (Москва)
  2. 2 д.м.н., зав. отделом экспериментальной и клинической фармакологии, Центр медицины ГНУ ВИЛАР Россельхозакадемии (Москва)
  3. 3 д.фарм.н., профессор, первый зам. директора, ГНУ ВИЛАР Россельхозакадемии (Москва)
  4. 4 к.м.н., зав. лабораторией фармакологии, отдел экспериментальной и клинической фармакологии, Центр медицины, ГНУ ВИЛАР Россельхозакадемии (Москва)
  5. 5 мл. науч. сотрудник, лаборатория фармакологии, отдел экспериментальной и клинической фармакологии, Центр медицины, ГНУ ВИЛАР Россельхозакадемии (Москва)

Abstract

The gastro-protective activity of the grape leaves red extract dry (GLRED) has been evaluated in white non-linear male rats in experimental models of stomach ulcers induced by 96 % ethanol (1 ml/rat, decapitation after 1 hour) and induced by indometacin (30 mg/kg, decapitation after 24 hour). GLRED was administered in concentration 10 mg/kg and 100 mg/kg. Ranitidine as comparative drug in concentration 100 mg/kg was administered. GLRED and Ranitidine were introduced intraperitoneally for 3 days. Stomach and duodenum of rats after decapitation were extracted and quantity of ulcers and ulcer area (by microscope MBS-10), Index Paulus (IP) and Therapeutic Effect (TE - ratio of experimental IP to control IP) were calculated. The Student t-test was used for estimation of statistical confidence. Significant gastroprptective effect was found after introduction of GLRED (10 mg/kg) ? on experimental model of ulcers caused by ethanol area of gastric ulcer decreased by 78,6 % (TE=4,7) and on indometacin-induced ulcer area of gastric ulcer decreased by 45,0 % (TE=1,8, p < 0,05). Introduction of GLRED (100 mg/kg) reduced the gastric ulcer area by 92,2 % (TE=12,9, p < 0,05) ? ehanol-induced ulcers, and by 81,2 % (TE=5,3) ? indometacin-induced ulcers. Thus, marked dose-dependent gastroprotective effect of GLRED was found. The reliable gastro-protective effect of Ranitidine on indometacin-induced model of stomach ulcers was found - ulceration reduced by 58,4 %, TE = 2,4. Decrease of ulceration after introduction of Ranitidine on ethanol-induced model of stomach ulcer was insignificant (decrease by 10,5 %, p > 0,05). It was found that gastro-protective activity of GLRED (100 mg/kg) exceeded the activity of Ranitidine (100 mg/kg) 2,2 times on indometacin-induced ulcers and 11,7 times ethanol-induced ulcers.

How to cite

Трифонов Ю.А., Колхир В.К., Сокольская Т.А., Ферубко Е.В., Курманов Т.Р. Фармакологическое исследование противоязвенного действия винограда листьев красных экстракта сухого (Vitis vinifera L.) // Вопросы биологической, медицинской и фармацевтической химии. 2013. № 11. С. 64–69.

References

  1. Shatixin A.I. Regeneracziya i czitoprotekcziya slizistoj obolochki pri zabolevaniyax zheludka // V kn.: XIV Rossijskij naczional'ny'j Kongress «Chelovek i lekarstvo». Lekczii dlya praktikuyushhix vrachej. M. 2008. T. 1. S. 278-295.
  2. Loginov A.S., Vasil'ev Ju.V., Il'chenko A.A., Vy'soczkaya R.A., Bendikov E'.A. Klinicheskaya e'ffektivnost' i mexanizm dejstviya preparata Venter u bol'ny'x yazvennoj bolezn'yu // V kn.: Primenenie preparata Venter (Sukral'fat) v lechenii bol'ny'x yazvennoj bolezn'yu. Materialy' simpoziuma / pod red. A.S. Loginova M. 1987. S. 14-25.
  3. Nord K.S. Peptic ulcer disease in pediatric population // Pediatr. Clin. N. Amer. 1988. V. 35. P. 117.
  4. Sel'e G. Ocherki ob adaptaczionnom sindrome. M.: Medgiz. 1960. S. 254.
  5. Cimmerman Ja.S. Xronicheskij gastrit i yazvennaya bolezn' // Ocherki klinicheskoj gastroe'nterologii. Perm': Permskaya gos. med. akademiya. 2000. S. 30.
  6. Obolenczeva G.V. Farmakologicheskoe izuchenie vliyaniya nekotory'x prirodny'x i modificzirovanny'x polisaxaridov na funkczii pishhevaritel'noj sistemy': Avtoref. ... diss. dokt. med. nauk. 1984. S. 40.
  7. Bul'on V.V., Xny'chenko L.K., Sapronov N.S. i dr. Cikloferan v terapii yazvy' dvenadczatiperstnoj kishki u kry's // E'ksperimental'naya i klinicheskaya farmakologiya. 2001. T. 64. № 6. S. 41-44.
  8. Shirokova K.I., Vasilenko V.X., Grebenev A.L. Jazvennaya bolezn' // V kn.: Bolezni zheludka i dvenadczatiperstnoj kishki. M.: Mediczina. 1981. S. 77-144.
  9. Loginov A.S., Aruin L.I., Il'chenko A.A. Jazvennaya bolezn' i Helicobacter pylori. Novy'e aspekty' patogeneticheskoj terapii. Moskva. 1993. S. 139-140.
  10. Dul V.N. Vinograd kul'turny'j - Vitis vinifera L. Novy'j istochnik makro- i mikroe'lementov // Vestnik VGU. Ser. «Geografiya, geoe'kologiya». 2010. № 2. S. 76-78.
  11. Kosar M., Kupeli E., Malyer H. et al. Effect of brining on biological activity of leaves of Vitis vinifera L., (Cv. Sultani Cekirdeksiz) from Turkey // J. Agric Food Chem. 2007. V. 55. № 11. P. 596-603.
  12. Orhan N., Aslan M., Orhan D.D., et al. In-vivo assessment of antidiabetic and antioxidant activities of grapevine of leaves (Vitis vinifera) in diabetic rats // J. Ethnopharmacol. 2006. V. 108b, N. 2. P. 280-286.
  13. Evropejskaya konvencziya o zashhite pozvonochny'x zhivotny'x, ispol'zuemy'x dlya e'ksperimentov ili v iny'x nauchny'x czelyax. Strasburg. 18 marta 1986 g.
  14. Stat'ya 631. Spirt e'tilovay'j 95 %. GF XM. Mediczina. 1968. S. 644-646.
  15. Robert A., Nezamis J.E., Lancaster C., Davis J.P., Field S.O., Hanchar A.J. Mild irritants prevent gastric necrosis through «adaptive cytoprotection» mediated by prostaglandins // Am. J. Physiol. 1983. V. 245. P. 113-121.
  16. Bhargava K.P., Gupta M.B. and Tangri K.K. Mechanism of ulcerogenic activity of indomethacin and oxyphenbutazone // Eur. J. Pharmac. 1973. V. 22. P. 191-195.
  17. Pauls F., Wick A.N., Mackey E.M. An assay method for anti-ulcer substances // Gastroenterology. 1947. V. 8. P. 774-782.
  18. Obolenczeva G.V. Farmakologicheskoe issledovanie protivoyazvennogo dejstviya nekotory'x flavonoidov: Avtoref. ... diss. kand. med. nauk. 1964. 18 s.
  19. Metodicheskie rekomendaczii po statisticheskoj obrabotke rezul'tatov doklinicheskix issledovanij lekarstvenny'x sredstv. Rukovodstvo po provedeniyu doklinicheskix issledovanij lekarstvenny'x sredstv. Ch. 1. M.: FGBU «NCE'SMP». 2012. S. 891-942.
  20. «Boehringer Ingelheim». Antistaks® kapsuly', 180 mg. Instrukcziya po mediczinskomu primeneniyu.